Bob Brousseau

Julie Osborne joins SK pharmteco as VP, Global HR

News / By

We are pleased to announce that Julie Osborne has joined SK pharmteco as VP, Global HR. Julie has held several progressing roles supporting Global Marketing and sales, Controlled Substance Manufacturing, Regulatory Affairs, Quality, and R&D. As a Division Vice President for Global Pharmaceutical R&D, Julie maintained Business and HR responsibilities across six countries, including Japan, […]

Julie Osborne joins SK pharmteco as VP, Global HR Read More »

AI in Bio/Pharma Supply Chain: SK pharmteco Expert Shares Insights at DCAT Week

News / By

At DCAT Week, the buzz wasn’t just about the latest drug discovery techniques – it was about AI’s growing influence on bio/pharma supply chains.  SK pharmteco was at the forefront of this conversation when Jeet Sarkar, SK pharmteco’s global head of Information Technology (IT), took center stage on a panel discussing how biopharma companies utilize

AI in Bio/Pharma Supply Chain: SK pharmteco Expert Shares Insights at DCAT Week Read More »

Shedding Light on Photo-Stability Forced Degradation

Blog / By

Forced Degradation is the testing of a drug product or drug substance using situations more taxing than those if conditions were simply accelerated. This type of stability testing is designed to demonstrate various degradation pathways within the product or substance and assists with developing the product itself and its packaging. Within forced degradation testing, a

Shedding Light on Photo-Stability Forced Degradation Read More »

Extractables and Leachables

Blog / By

Extractables and Leachables (E&L) are essential areas of concern for the pharmaceutical and food industries, specifically regarding their packaging, usage components (e.g., medical devices or syringes), and the manufacturing chain. We will examine testing of analysis of them within pharmaceutical applications. The two terms are related but distinct, each with its own analytical requirements.    Definitions of

Extractables and Leachables Read More »

SK pharmteco 2024 Continuous Flow Symposium

Events / By

SK pharmteco, the world leader in continuous flow processing, is hosting a symposium for customers and key contacts entitled ‘Continuous Process Applications in the Pharmaceutical Industry’, which will be held on Tuesday, May 21st, at the Boston Marriott Hotel Cambridge, 50 Broadway, Cambridge, MA 02142. For accommodations, contact Le Meridian. Agenda 8:00 – 8:45 Registration Open 8:45

SK pharmteco 2024 Continuous Flow Symposium Read More »

Nitrosamines: An Overview

Blog / By

Nitrosamines are organic compounds found in the human diet and other environmental outlets. Being potent carcinogens that can cause tumors in nearly all organs, they have been classified as genotoxic impurities (GTIs). There are guidelines and rulings by various regulatory organizations, including the FDA, EPA, EMA, and the IARC (International Agency for Research on Cancer).

Nitrosamines: An Overview Read More »

From The Korea Economic Daily: SK pharmteco Launches New Viral Vector Platforms, Key for CGT

News / By

The Korean CDMO’s new viral vector platforms can significantly save the production time and cost of AAV and lentiviral vectors By Ji-Hyun Lee SK pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two new viral vector platforms that are expected to save the time and cost of

From The Korea Economic Daily: SK pharmteco Launches New Viral Vector Platforms, Key for CGT Read More »

Links
Compliance
Twitter Linkedin-in Facebook-square
Copyright ©2024 by SK pharmteco Inc. All Rights Reserved
Scroll to Top

Enter your details to access Marketing Materials

"*" indicates required fields